ClinicalTrials.gov
ClinicalTrials.gov Menu

Biomarkers and Response to Natalizumab for Multiple Sclerosis Treatment (Bionat2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00942214
Recruitment Status : Completed
First Posted : July 20, 2009
Last Update Posted : March 30, 2011
Sponsor:
Information provided by:
University Hospital, Toulouse

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2011
  Actual Study Completion Date : March 2011